Sanofi News and Activities

Presence

Sanofi develops, makes, and sells medicines and vaccines. Its products serve patients, healthcare providers, hospitals, and public health agencies in areas such as specialty care, general medicine, and immunization.

Sanofi products and services overview:

Prescription medicines
Vaccines
Specialty care
Consumer healthcare

Revenue: ~$45 billion

Employees: 84,000

Headquarters: Paris, France

Sanofi is one of the...

Sanofi is a company listed under the stock ticker SAN (FR).

Sanofi has a direct presence in 33 countries.

Sanofi has 46 subsidiaries including Blueprint Medicines, Euroapi and Genzyme Denmark.

They are in:

Acquisition, funding and merger involving Sanofi.

Sanofi has acquired Dynavax Technologies (posted on February 23 2026).
Sanofi has announced the acquisition of Dynavax Technologies (posted on December 29 2025).
Sanofi has announced the acquisition of Dren Bio (posted on December 18 2025).
Sanofi has acquired Vicebio (posted on December 11 2025).
Sanofi has acquired Vigil Neuroscience (posted on August 6 2025).
Blueprint Medicines and Sanofi have merged (posted on July 21 2025)..
Sanofi has announced the acquisition of Blueprint Medicines (posted on June 2 2025).
Sanofi has announced the acquisition of Vigil Neuroscience (posted on May 29 2025).
See more news about Sanofi Hide news involving Sanofi

Executives

View the org chart displaying its 386 main executives

Most searched biographies at Sanofi

Popular executive movements at Sanofi

Christel Heydemann has joined the company as Director (posted on May 7 2026).
Emy Rossi, Head of Talent Management Global Corporate Functions, has left the company (posted on April 23 2026).
Fabrizio Guidi, Head, Go To Market Capabilities, has left the company (posted on April 23 2026).

Click here to view some more movements at Sanofi

Create your alert
to follow the executive moves at Sanofi.